As a result of the end of the approval periods of the active substances Adoxophyes orana granulovirus strain BV-0001, spiromesifen and Bacillus firmus I-1582, 4 authorisations […]
As a result of the entry into force of Regulation (EU) 2023/1436 of 10 July 2023 concerning the non-renewal of dimoxystrobin approval, 3 authorisations and 4 parallel trade […]
As a result of the entry into force of Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of oxamyl approval, 3 authorisations for plant […]
Work aimed at anticipating the withdrawal of the highest concern active substances and reinforcing the mobilisation of the stakeholders concerned to broaden the range of solutions […]